Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Advanced Energy Industries Director Anne DelSanto Sells $82.3K of Stock
Anne DelSanto, Director, sold 270 shares of Advanced Energy Industries Inc at $304.76 a share, worth $82.3K in total on Oct 5, 2026. Shares held after the trade: 7,682 (-3.4%).
Goldman Sachs Real Estate Finance Trust Capital Raise of $5.34M
Goldman Sachs Real Estate Finance Trust Inc sold unregistered shares of Class I and Class S common stock for aggregate consideration of approximately $5.34 million in an ongoing private offering. The company also announced monthly distributions for September 2026 and the origination of three new mortgage loans totaling $237.5 million across industrial and office properties.
Pimco Dynamic Income Strategy Fund Insider Saba Capital Management L.P. Sells $239K of Stock
Saba Capital Management L.P. sold 11,572 shares of Pimco Dynamic Income Strategy Fund at $20.67 a share, worth $239K in total on Oct 5, 2026. Shares held after the trade: 6,266,175 (-0.2%).
Gabelli Healthcare & WellnessRx Trust Insider Saba Capital Management L.P. Buys $16.6K of Stock
Saba Capital Management L.P. bought 1,775 shares of Gabelli Healthcare & WellnessRx Trust at $9.38 a share, worth $16.6K in total on Oct 5, 2026. Shares held after the trade: 2,164,547 (+0.1%).
New Germany Fund Insider Saba Capital Management L.P. Buys $264K of Stock
Saba Capital Management L.P. bought 25,144 shares of New Germany Fund Inc at $10.51 a share, worth $264K in total on Oct 5, 2026. Shares held after the trade: 3,743,677 (+0.7%).
Partners Group Private Equity Fund Insider Partners Group Private Equity II LLC Sells $30M of Stock
Partners Group Private Equity II LLC sold 13,619,649 shares of Partners Group Private Equity Fund, LLC at $2.20 a share, worth $30M in total on Oct 1, 2026.
Mexico Fund Insider Saba Capital Management L.P. Buys $520K of Stock
Saba Capital Management L.P. bought 25,900 shares of Mexico Fund Inc at $20.09 a share, worth $520K in total on Oct 5, 2026. Shares held after the trade: 2,393,834 (+1.1%).
EQT Exeter Real Estate Income Trust Capital Raise of $2.14M
EQT Exeter Real Estate Income Trust, Inc. issued multiple classes of common stock in private placements to accredited investors and independent directors. The transactions included approximately $1.87 million of Class A-II shares on October 1, 2026, and approximately $0.27 million across Class A-I and Class A-II shares on September 10, 2026. The shares were issued under the company's distribution reinvestment plan and private offerings exempt from registration.
Vesta Real Estate Corporation, S.A.B. de C.V VP Investment Officer Melgar Pablo Barcos Sells $21.6K of Stock
Melgar Pablo Barcos, VP Investment Officer, sold 6,154 shares of Vesta Real Estate Corporation, S.A.B. de C.V. at $3.51 a share, worth $21.6K in total on Aug 25, 2026. Shares held after the trade: 5,000 (-55.2%).
Helmerich & Payne provided a financial and operational update for its fiscal fourth quarter of 2026, expecting direct margins for its North America, International, and Offshore Solutions segments to be at or near the high end of previous guidance. The company noted particularly strong performance in its International Solutions segment with expected direct margins of approximately $45 million for the quarter. Management reaffirmed its commitment to reaching a 1x net debt to adjusted EBITDA ratio by the end of calendar year 2027.
Incordex Corp. appointed Mr. Chen Wang to its Board of Directors, effective September 29, 2026. Mr. Wang brings extensive experience in e-commerce and pharmaceutical education operations, having previously served as Chairman of Yunnan Jinshengchang Technology and Trade Co., Ltd. and President of Global Pharmaceutical Education Operations at Meixin E-commerce Company.
Bioforce Nanosciences Holdings M&A Deal with CELT eResources, LLC
Bioforce Nanosciences Holdings, Inc. received an assignment of an oil and gas lease covering approximately 40.19 acres in Liberty County, Texas, from CELT eResources, LLC. The transaction, which includes all related wells, equipment, and permits, was approved by the Liberty County Clerk's Office on October 2, 2026. Both the assignor and assignee are controlled by Nexus Capital Investments, Inc.
Thomas F. DeBruine, COO, sold 1,569 shares of Brady Corp at $85.00 a share, worth $133K in total on Oct 6, 2026. Shares held after the trade: 8,381 (-15.8%).
Ebay President and CEO Jamie Iannone Sells $2.37M of Stock
Jamie Iannone, President and CEO, sold 22,220 shares of Ebay Inc at $105.28 to $107.14 a share (average $106.70) in 5 transactions, worth $2.37M in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 215,159 (-1.3%).
Butler National Corporation's Board of Directors authorized a $10 million increase to its existing stock repurchase program, bringing the total available authorization to approximately $11.9 million. The program was also extended through April 30, 2029, allowing for open market or privately negotiated transactions. Management intends to use the buyback as part of its capital allocation strategy to return value to shareholders based on market conditions.
SDR Drone, Inc. disclosed the discovery of two historical administrative orders (from 2014 and 2018) issued against the company and its former CEO, Robert L. Cashman, for securities violations. The orders involve a Desist and Refrain Order from California and a Consent Order from South Carolina related to misrepresented stock sales. The company is disclosing these legacy regulatory issues as part of its assessment of their impact on a pending Regulation A offering.
VIP Play Debt Financing Update with Rick Hackel and The Access Fund I, LP
VIP Play, Inc. entered into amendments to extend the maturity dates of $450,000 in outstanding convertible promissory notes. The maturity for $300,000 in notes held by Rick Hackel was extended to February 28, 2027, while the $150,000 note held by The Access Fund I, LP was extended to August 31, 2027.
Star Bulk Carriers Insider Koert Erhardt Sells $182K of Stock
Koert Erhardt sold 6,000 shares of Star Bulk Carriers Corp. at $30.39 a share, worth $182K in total on Oct 5, 2026. Shares held after the trade: 10,080 (-37.3%).
Cadrenal Therapeutics has initiated a formal strategic process to evaluate opportunities to maximize shareholder value, including potential licensing, asset sales, partnerships, or business combinations. The company has engaged Tungsten Advisors as its exclusive financial advisor following alignment with the FDA on a Phase 3 pathway for its lead asset, CAD-1005.
Pulse Biosciences reached its enrollment target of 164 evaluable patients in the NANOPULSE-AF IDE pivotal clinical study three months ahead of schedule. The study evaluates the safety and effectiveness of the nPulse Cardiac Catheter System for treating drug-resistant paroxysmal atrial fibrillation. Primary safety and effectiveness endpoints will be assessed at 6 and 12 months post-ablation to support future regulatory submissions.
Coffee Holding Co., Inc. announced that its Board of Directors has authorized a new share repurchase program to buy back up to $2.5 million of its common stock. The company plans to fund the repurchases using available cash and future cash flow from operations, citing a belief that the current stock price does not reflect the company's underlying fundamentals.
Prerna Sachdeva, Chief Accounting Officer and principal accounting officer, has resigned effective November 2, 2026, to pursue other opportunities. CFO Cassandra Hudson will assume the role of principal accounting officer on an interim basis starting November 3, 2026, while the company searches for a permanent replacement.
BioNexus Gene Lab Licensing Deal with Ruanyun Edai Technology Inc. Worth $3.5M
BioNexus Gene Lab Corp. entered into an exclusive 10-year licensing agreement with Ruanyun Edai Technology Inc. (RYET) for the CogniAI document-intelligence platform in the Malaysian healthcare sector. The company will issue 410,000 shares to satisfy the $3.5 million license consideration and an additional 150,000 shares in exchange for 500,000 RYET ordinary shares. BioNexus intends to use the platform to target Malaysia's RM1 billion public healthcare digitalization program.
Onfolio Holdings received an extension from Nasdaq until November 23, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement. The company originally received a deficiency notice in May 2026 and must now evidence compliance by the new deadline to avoid potential delisting. The extension has no immediate effect on the trading of the company's common stock (ONFO) or warrants (ONFOW).
Modine Manufacturing Company completed the spin-off of its Performance Technologies business and its subsequent combination with Gentherm Incorporated via a Reverse Morris Trust transaction. This filing provides the required unaudited pro forma financial information showing the impact of the divestiture on Modine's balance sheet and operations, treating the business as discontinued operations.
Ultragenyx Pharmaceutical Inc. entered into an asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million in cash. The PRV was recently awarded by the FDA following the approval of GENGLYCOS for the treatment of glycogen storage disease type Ia. Under a prior agreement, the company will pay 20% of the gross proceeds from this sale to the NIH.
BioCardia announced it will present the trial design and scientific support for its CardiAMP HF II Study at the Heart Failure Society of America Annual Scientific Meeting. The study evaluates a high-dose autologous cell treatment for patients with ischemic heart failure of reduced ejection fraction (HFrEF) who remain symptomatic despite medical therapy.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.46M of Stock
Japan Post Holdings Co. Ltd. sold 13,000 shares of Aflac Inc at $112.25 a share, worth $1.46M in total on Oct 5, 2026. Shares held after the trade: 50,407,190 (-0.0%).
Envoy Medical entered into a Dismissal Agreement with Atlas Merchant Capital SPAC Fund I LP to resolve litigation in the Delaware Court of Chancery. The litigation concerned allegations that Atlas was not permitted to redeem its shares during the company's September 2023 business combination. All claims will be dismissed with prejudice with no payment required from Envoy Medical or other defendants.
AgomAb Therapeutics Insider David R. Epstein Buys $86.3K of Stock
David R. Epstein bought 10,000 shares of AgomAb Therapeutics NV at $8.57 to $8.70 a share (average $8.63) in 2 transactions, worth $86.3K in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 10,000 (+100.0%).